Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.
UB researchers have received a $$3.28 million grant from the NIH to investigate the use of structured financial incentives in lowering cardiovascular disease (CVD) risk among African Americans facing food insecurity.
A paper published today explains why there needs to be a shift in cannabis policies to a public health approach as opposed to the prevailing, more punitive approach that pushes abstinence instead of public education.
Updated results from a phase 3 clinical trial are expected to change the way advanced stage classic Hodgkin lymphoma is treated in newly diagnosed adolescents and adults.
UB's new Aging and Resilience Research Center on The Brothers of Mercy Wellness Campus in Clarence, N.Y. is dedicated to identifying the factors that contribute to healthy, resilient aging.
